Syneron stock falls after approval delayed NEW YORK -- Syneron Medical Ltd. stock fell Tuesday after the US Food and Drug Administration delayed approval of the medical device maker #39;s cellulite product. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 